News & Updates

Show Multimedia Only

Expanding HPV vaccines to mid-adults: Is it worth the shot?

01 Jan 2025

Vaccination against human papillomavirus (HPV) among adults aged 27–45 years (mid-adults) is less cost-effective and generates a greater number needed to vaccinate (NNV) when compared with vaccination of persons aged 26 years and below, reports a study.

Expanding HPV vaccines to mid-adults: Is it worth the shot?

01 Jan 2025

Poor control over work linked to burnout among clinicians

31 Dec 2024

Having poor control over some aspects of work can lead to burnout among clinicians, reports a US study. For some, this may also result in having intentions to reduce effort or leave the organization.

Poor control over work linked to burnout among clinicians

31 Dec 2024

Kids with Down syndrome have poorer QoL than typically developing children

31 Dec 2024 by

A systematic review and meta-analysis show that children with Down syndrome (DS) have lower quality of life (QoL) than typically developing (TD) children.

Kids with Down syndrome have poorer QoL than typically developing children

31 Dec 2024

PALOMA-3: Subcutaneous amivantamab makes the grade in Asians with EGFR+ NSCLC

30 Dec 2024 by

For Asian patients with EGFR-mutated advanced non-small-cell lung cancer (NSCLC), subcutaneous (SC) delivery of amivantamab plus lazertinib does not alter the drug’s pharmacokinetic and efficacy profile compared with the intravenous (IV) approach and is associated with fewer infusion-related reactions, according to a subgroup analysis of the phase III PALOMA-3 trial.

PALOMA-3: Subcutaneous amivantamab makes the grade in Asians with EGFR+ NSCLC

30 Dec 2024

New model using psychosocial factors predicts incident CHD

30 Dec 2024

A polysocial score (PSS) for coronary heart disease (CHD) can predict incident CHD, suggests a study. Combining PSSCHD with a polygenic risk score (PRS) results in improvements in the performance of clinical risk calculators.

New model using psychosocial factors predicts incident CHD

30 Dec 2024

NT-proBNP predicts cardiorenal complications in Chinese patients with T2D

30 Dec 2024 by

Elevated N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels independently predict cardiorenal complications in Chinese patients with type 2 diabetes (T2D) and can be utilized as a clinical prognostic biomarker for risk stratification to enable more intensive organ-protective treatment in those at risk, a study involving 1,993 patients enrolled in the Hong Kong Diabetes Biobank has shown.

NT-proBNP predicts cardiorenal complications in Chinese patients with T2D

30 Dec 2024

Rise in gender dysphoria in SG indicates greater self-awareness

29 Dec 2024 by

New diagnoses of gender dysphoria (GD) at younger ages are increasing in Singapore, suggesting greater self-awareness and willingness to seek help among younger individuals.

Rise in gender dysphoria in SG indicates greater self-awareness

29 Dec 2024

Left heart geometry changes predict NOAF hypertensive patients

28 Dec 2024

The changes seen in left heart geometry may be used as a marker to predict the development of new-onset atrial fibrillation (NOAF) in patients with hypertension, suggests a study.

Left heart geometry changes predict NOAF hypertensive patients

28 Dec 2024

$Osteoporotic fractures tied to death, allograft loss in kidney transplant recipients$

Osteoporotic fractures tied to death, allograft loss in kidney transplant recipients

28 Dec 2024

Osteoporotic fractures do not occur frequently among kidney transplant recipients but when they do, they contribute to increased risks of death and allograft loss, according to a retrospective cohort study.

Osteoporotic fractures tied to death, allograft loss in kidney transplant recipients

28 Dec 2024

Rezvilutamide + ADT delivers improved outcomes for mHSPC patients regardless of age

27 Dec 2024 by

The combination of rezvilutamide plus androgen-deprivation therapy (ADT) proves to be efficacious and well-tolerated in the treatment of patients with high-volume, metastatic, hormone-sensitive prostate cancer (mHSPC) across all age groups, according to a post hoc analysis of the phase III CHART trial.

Rezvilutamide + ADT delivers improved outcomes for mHSPC patients regardless of age

27 Dec 2024

News & Updates

Filter by Specialty:

Specialty:

Expanding HPV vaccines to mid-adults: Is it worth the shot?

Expanding HPV vaccines to mid-adults: Is it worth the shot?

Poor control over work linked to burnout among clinicians

Poor control over work linked to burnout among clinicians

Kids with Down syndrome have poorer QoL than typically developing children

Kids with Down syndrome have poorer QoL than typically developing children

PALOMA-3: Subcutaneous amivantamab makes the grade in Asians with EGFR+ NSCLC

PALOMA-3: Subcutaneous amivantamab makes the grade in Asians with EGFR+ NSCLC

New model using psychosocial factors predicts incident CHD

New model using psychosocial factors predicts incident CHD

NT-proBNP predicts cardiorenal complications in Chinese patients with T2D

NT-proBNP predicts cardiorenal complications in Chinese patients with T2D

Rise in gender dysphoria in SG indicates greater self-awareness

Rise in gender dysphoria in SG indicates greater self-awareness

Left heart geometry changes predict NOAF hypertensive patients

Left heart geometry changes predict NOAF hypertensive patients

Osteoporotic fractures tied to death, allograft loss in kidney transplant recipients

Osteoporotic fractures tied to death, allograft loss in kidney transplant recipients

Rezvilutamide + ADT delivers improved outcomes for mHSPC patients regardless of age

Rezvilutamide + ADT delivers improved outcomes for mHSPC patients regardless of age